We are live on
!
Find out more
LI
LMCG Investments Portfolio holdings
AUM
$1.87B
1-Year Est. Return
50.61%
This Fund
S&P 500
This Quarter
Est. Return
+12.85%
1 Year Est. Return
+50.61%
3 Year Est. Return
+124.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.6B
AUM Growth
+$88.6M
(+5.9%)
Cap. Flow
-$48.8M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
27.87%
Holding
232
New
4
Increased
49
Reduced
146
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$10.7M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$9.66M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.58M |
| 4 |
Workday
WDAY
|
+$5.89M |
| 5 |
iShare MSCI Eurozone ETF
EZU
|
+$3.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$13.2M |
| 2 |
Northrop Grumman
NOC
|
+$9.09M |
| 3 |
Zimmer Biomet
ZBH
|
+$6.93M |
| 4 |
Newmont
NEM
|
+$5.77M |
| 5 |
Enphase Energy
ENPH
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Financials | 15.03% |
| 3 | Healthcare | 10.3% |
| 4 | Industrials | 8.69% |
| 5 | Consumer Discretionary | 7.57% |
Similar funds
LPU
P3I
BCIM
EPW
EAM
PCP
ACM
WRBC
LMCG Investments's Q2 2025 Portfolio in Review
As of Q2 2025, LMCG Investments held 232 positions worth $1.6B, up 5.9% from $1.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
LMCG Investments withdrew a net $48.8M in Q2 2025, closing 7 positions and reducing 146 holdings. Its most notable exit was Zimmer Biomet, an estimated $6.93M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, LMCG Investments opened a new position in iShares Core S&P 500 ETF worth $1.03M.
- LMCG Investments's largest Q2 2025 buy was iShares Core S&P 500 ETF: 1,652 shares worth $1.03M.
- LMCG Investments added most to Regeneron Pharmaceuticals in Q2 2025, an estimated $10.7M increase.
- LMCG Investments's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $13.2M.
- LMCG Investments fully exited Zimmer Biomet in Q2 2025, selling an estimated $6.93M.
- LMCG Investments's ten largest holdings make up 28% of its $1.6B portfolio in Q2 2025.
- LMCG Investments opened 4 new positions and closed 7 in Q2 2025.
- LMCG Investments's portfolio value rose 5.9% quarter-over-quarter to $1.6B.
Based on LMCG Investments's 13F filing for Q2 2025, filed 24 Jul 2025.